Publications by authors named "Davide Meani"

Claim this Profile
P
Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care.
Davide Meani, Mladen Solarić, Harri Visapää, Rose-Marie Rosén, Robert Janknegt

Ther Adv Urol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer: results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation.
Mladen Solarić, Anders Bjartell, Ursula Thyroff-Friesinger, Davide Meani

Ther Adv Urol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations.
Axel S Merseburger, Thomas Björk, James Whitehouse, Davide Meani

J Comp Eff Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis